WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924023763 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690909808001024 |
|---|---|
| author | Lisa Kivman Tabea Kraft Julia Rauser Rainer Boxhammer Stefan Hartle Brian Schwartz Paul Manser Leslie Chinn Uptal Patel Donna Flesher Krzysztof Kiryluk Jonathan Barratt |
| author_facet | Lisa Kivman Tabea Kraft Julia Rauser Rainer Boxhammer Stefan Hartle Brian Schwartz Paul Manser Leslie Chinn Uptal Patel Donna Flesher Krzysztof Kiryluk Jonathan Barratt |
| author_sort | Lisa Kivman |
| collection | DOAJ |
| format | Article |
| id | doaj-art-1ca8206ec8664d0c8b3c4e5eba14dbc3 |
| institution | DOAJ |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-1ca8206ec8664d0c8b3c4e5eba14dbc32025-08-20T03:21:11ZengElsevierKidney International Reports2468-02492025-02-01102S173S17410.1016/j.ekir.2024.11.354WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)Lisa Kivman0Tabea Kraft1Julia Rauser2Rainer Boxhammer3Stefan Hartle4Brian Schwartz5Paul Manser6Leslie Chinn7Uptal Patel8Donna Flesher9Krzysztof Kiryluk10Jonathan Barratt11Biomarkers and Bioanalytical Sciences, Human Immunology Biosciences, Inc, a Biogen company, South San Francisco, United StatesClinical Biomarkers, Morphosys AG, Planegg, GermanyClinical Pharmacology, MorphoSys AG, Planegg, GermanyClinical Biomarkers, Morphosys AG, Planegg, GermanyClinical Pharmacology, MorphoSys AG, Planegg, GermanyClinical Development, Human Immunology Biosciences, Inc, a Biogen Company, South San Francisco, United StatesBiostatistics, Human Immunology Biosciences, Inc, a Biogen Company, South San Francisco, United StatesClinical Pharmacology, Human Immunology Biosciences, Inc, a Biogen Company, South San Francisco, United StatesClinical Development, Human Immunology Biosciences, Inc, a Biogen Company, South San Francisco, United StatesBiomarker and Bioanalytical Sciences, Human Immunology Biosciences, Inc, a Biogen Company, South San Francisco, United StatesDivision of Nephrology, Department of Medicine, Columbia University, New York, United StatesMayer IgA Nephropathy Laboratory, University of Leicester, Leicester, United Kingdomhttp://www.sciencedirect.com/science/article/pii/S2468024924023763 |
| spellingShingle | Lisa Kivman Tabea Kraft Julia Rauser Rainer Boxhammer Stefan Hartle Brian Schwartz Paul Manser Leslie Chinn Uptal Patel Donna Flesher Krzysztof Kiryluk Jonathan Barratt WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) Kidney International Reports |
| title | WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) |
| title_full | WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) |
| title_fullStr | WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) |
| title_full_unstemmed | WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) |
| title_short | WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN) |
| title_sort | wcn25 318 felzartamab durably reduces disease relevant biomarkers through targeting of cd38 plasma cells and plasmablasts the upstream drivers of iga nephropathy igan |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924023763 |
| work_keys_str_mv | AT lisakivman wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT tabeakraft wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT juliarauser wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT rainerboxhammer wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT stefanhartle wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT brianschwartz wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT paulmanser wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT lesliechinn wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT uptalpatel wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT donnaflesher wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT krzysztofkiryluk wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan AT jonathanbarratt wcn25318felzartamabdurablyreducesdiseaserelevantbiomarkersthroughtargetingofcd38plasmacellsandplasmablaststheupstreamdriversofiganephropathyigan |